TriStar Health Partners

TVA Medical, Inc. is a medical device company based in Austin, Texas, specializing in the development and manufacturing of catheter-based equipment for treating end-stage renal disease and peripheral vascular diseases. Founded in 2009, TVA Medical focuses on innovative, minimally invasive therapies, notably its everlinQ endoAVF system, which creates an arteriovenous fistula using an endovascular approach to facilitate hemodialysis for patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. As of July 2018, TVA Medical operates as a subsidiary of Becton, Dickinson and Company.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, that focuses on developing innovative products for metabolic diseases linked to over-nutrition, such as obesity and diabetes. Established in 2007, the company has created a technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its flagship product, NS-0100, combines the natural compound leucine with a low dose of metformin to address type 2 diabetes, particularly for patients who experience gastrointestinal side effects from standard metformin treatment. NuSirt is currently conducting Phase 2 clinical trials to determine the optimal dosage of NS-0100. The company has filed eleven patent applications related to its technologies, with two patents already issued, and has successfully completed four clinical studies alongside various pre-clinical investigations.

Evermind, Inc. is a company based in Nashville, Tennessee, founded in 2012, that specializes in monitoring home appliances to enhance the safety and well-being of individuals living alone. Its primary product, also named Evermind, sends text messages or email notifications to users when appliances are activated or deactivated. This system enables caregivers and family members to receive updates on daily activities without intruding on the individual's privacy. By tracking the usage of various electrical devices such as coffee makers, lamps, and garage door openers, Evermind provides a modern solution reminiscent of traditional community watch practices, allowing individuals to maintain their independence while ensuring that their well-being is monitored effectively.

Advanced Catheter Therapies, Inc. is an early-stage medical device company based in Chattanooga, Tennessee, focused on the research and development of innovative catheter technologies aimed at treating vascular diseases. Founded in 2008, the company specializes in addressing conditions such as thrombosis, inflammation, occlusions, and restenosis. Among its offerings is the Occlusion Perfusion Catheter, a multi-lumen balloon catheter designed to temporarily block blood flow in specific regions, allowing for the localized delivery of therapeutic agents to both peripheral and coronary vasculature. Additionally, Advanced Catheter Therapies is developing devices to combat restenosis and catheters for endovascular debulking to clear blocked blood vessels. The company, previously known as Atlanta Catheter Therapies, Inc., rebranded in October 2011 to reflect its expanded focus on advanced catheter solutions.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Preferral is a referral management system designed to streamline the referral process between primary care practices and specialists. Founded in 2013 by Jon Gautsch and headquartered in Nashville, Tennessee, the platform allows healthcare providers to manage, customize, and analyze patient referrals efficiently. By offering online referral forms that can be easily integrated into practice websites, Preferral enables patients to schedule appointments at their convenience, thereby improving access to care. This system not only reduces administrative costs for healthcare providers but also enhances communication between them. Additionally, Preferral offers valuable insights into referral relationships, aiding practices in refining their marketing efforts.

InvisionHeart is a company focused on enhancing cardiac care through innovative technology. It has developed a mobile electrocardiograph system that captures vital cardiac data, allowing a network of healthcare professionals—including physicians, nurses, and technicians—to securely access and annotate patient electrocardiogram tracings. The technology was initially created by a collaborative team of physicians and engineers at Vanderbilt University, addressing practical clinical challenges faced in heart care. With a strong leadership team and a dedicated clinical advisory board, InvisionHeart aims to improve the quality of care for heart patients, ensuring that essential cardiac information is readily available to healthcare providers regardless of their location.

Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Bjond Inc. is a technology company based in Columbus, Ohio, founded in 2012. It specializes in automated workflow, real-time decision support, and behavior change software designed for both consumers and businesses across various industries. The company's innovative platform enables users, regardless of their technical expertise, to create interactive content and automated expert workflows tailored to any subject. In the healthcare sector, Bjond's software assists patients by providing dynamic decision support and promoting behavior change, ultimately fostering a continuous cycle of data-driven care that enhances patients' lives and makes the treatment process more engaging.

GenomOncology, LLC is a Cleveland-based genomics technology and services company dedicated to advancing precision medicine. Established in 2012, the company specializes in translating next-generation sequencing (NGS) data into actionable insights for clinicians and researchers. Its flagship product, the GO Clinical Workbench, provides a decision support system that processes raw sequencing data to generate clinical reports based on the molecular profiles of individual tumor genomes. Additionally, GenomOncology offers GenomAnalytics, a platform designed for rapid genome analysis and discovery, and igniteIQ, which extracts clinically relevant data from various report formats to convert it into discrete data elements. The company also supports assay validation, integration with laboratory information systems and electronic medical records, and custom feature development, addressing a comprehensive range of needs within healthcare institutions to enhance cancer care and patient outcomes.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Quire, LLC is a Memphis-based company specializing in population health management through its innovative platform, Quire. This system transforms unstructured clinical notes and electronic medical records (EMRs) into structured, accessible data, allowing healthcare organizations to uncover trends and patterns within patient populations. Quire enables users to categorize, organize, and visualize patient information, facilitating the identification and treatment of high-risk individuals while also targeting healthcare spending demographics. The platform incorporates predictive analytics, automatic learning, and concept matching to enhance provider evaluation and resource allocation. By considering social and environmental factors in its analysis, Quire ensures that healthcare practices gain comprehensive insights into patient risk across their populations. Founded in 2003, Quire was previously known as Computable Genomix, LLC.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

Preferral is a referral management system designed to streamline the referral process between primary care practices and specialists. Founded in 2013 by Jon Gautsch and headquartered in Nashville, Tennessee, the platform allows healthcare providers to manage, customize, and analyze patient referrals efficiently. By offering online referral forms that can be easily integrated into practice websites, Preferral enables patients to schedule appointments at their convenience, thereby improving access to care. This system not only reduces administrative costs for healthcare providers but also enhances communication between them. Additionally, Preferral offers valuable insights into referral relationships, aiding practices in refining their marketing efforts.

VenX Medical LLC is a medical device company based in Nashville, Tennessee, focused on developing innovative treatments for venous insufficiency, particularly targeting varicose veins. The company specializes in microvenous avulsion technology, offering devices such as VenX Reach and Nanophlebectomy. VenX Reach is a minimally invasive disposable device that effectively treats small to medium-sized lower limb veins, including reticular and spider veins, and can be used alongside other vein therapies like endovenous ablation and sclerotherapy. Nanophlebectomy, another of VenX Medical's offerings, is a handheld device designed to disrupt the structure of spider and reticular veins, promoting coagulation and elimination through a transdermal approach. Incorporated in 2009, VenX Medical aims to provide less invasive solutions for patients suffering from vein-related conditions.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

TVA Medical, Inc. is a medical device company based in Austin, Texas, specializing in the development and manufacturing of catheter-based equipment for treating end-stage renal disease and peripheral vascular diseases. Founded in 2009, TVA Medical focuses on innovative, minimally invasive therapies, notably its everlinQ endoAVF system, which creates an arteriovenous fistula using an endovascular approach to facilitate hemodialysis for patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. As of July 2018, TVA Medical operates as a subsidiary of Becton, Dickinson and Company.

Quire, LLC is a Memphis-based company specializing in population health management through its innovative platform, Quire. This system transforms unstructured clinical notes and electronic medical records (EMRs) into structured, accessible data, allowing healthcare organizations to uncover trends and patterns within patient populations. Quire enables users to categorize, organize, and visualize patient information, facilitating the identification and treatment of high-risk individuals while also targeting healthcare spending demographics. The platform incorporates predictive analytics, automatic learning, and concept matching to enhance provider evaluation and resource allocation. By considering social and environmental factors in its analysis, Quire ensures that healthcare practices gain comprehensive insights into patient risk across their populations. Founded in 2003, Quire was previously known as Computable Genomix, LLC.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Evermind, Inc. is a company based in Nashville, Tennessee, founded in 2012, that specializes in monitoring home appliances to enhance the safety and well-being of individuals living alone. Its primary product, also named Evermind, sends text messages or email notifications to users when appliances are activated or deactivated. This system enables caregivers and family members to receive updates on daily activities without intruding on the individual's privacy. By tracking the usage of various electrical devices such as coffee makers, lamps, and garage door openers, Evermind provides a modern solution reminiscent of traditional community watch practices, allowing individuals to maintain their independence while ensuring that their well-being is monitored effectively.

Cerebrotech Medical Systems, Inc. is a company specializing in the development of non-invasive monitoring technology for patients recovering from stroke or traumatic brain injury. The company's flagship product, the Cerebrotech monitor, is designed to facilitate the early detection of cerebral fluid accumulation, such as edema or bleeding, which can arise from various neurological conditions. This continuous monitoring capability provides healthcare professionals with critical information about changes in brain fluid levels before an increase in intracranial pressure occurs, enabling timely interventions to prevent potential brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes by addressing the limitations of current monitoring technologies, which are often invasive or provide only transient data.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diabetes Care Group, Inc. is a healthcare provider specializing in diabetes clinical care services for individuals with diabetes and metabolic diseases. Founded in 1986 and based in Jackson, Mississippi, the company integrates a multidisciplinary approach that includes medical management, patient education, behavioral modification, and individualized nutrition counseling. Their services are designed to enhance patient self-management and improve clinical outcomes while also aiming to reduce overall medical and social costs associated with diabetes. The company employs a team of experienced professionals, including board-certified physicians, registered nurse educators, registered dieticians, and medical assistants, all dedicated to delivering effective diabetes care. Diabetes Care Group has established a track record of significant improvements in health outcomes for patients facing the challenges of diabetes.

Cerebrotech Medical Systems, Inc. is a company specializing in the development of non-invasive monitoring technology for patients recovering from stroke or traumatic brain injury. The company's flagship product, the Cerebrotech monitor, is designed to facilitate the early detection of cerebral fluid accumulation, such as edema or bleeding, which can arise from various neurological conditions. This continuous monitoring capability provides healthcare professionals with critical information about changes in brain fluid levels before an increase in intracranial pressure occurs, enabling timely interventions to prevent potential brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes by addressing the limitations of current monitoring technologies, which are often invasive or provide only transient data.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Diabetes Care Group, Inc. is a healthcare provider specializing in diabetes clinical care services for individuals with diabetes and metabolic diseases. Founded in 1986 and based in Jackson, Mississippi, the company integrates a multidisciplinary approach that includes medical management, patient education, behavioral modification, and individualized nutrition counseling. Their services are designed to enhance patient self-management and improve clinical outcomes while also aiming to reduce overall medical and social costs associated with diabetes. The company employs a team of experienced professionals, including board-certified physicians, registered nurse educators, registered dieticians, and medical assistants, all dedicated to delivering effective diabetes care. Diabetes Care Group has established a track record of significant improvements in health outcomes for patients facing the challenges of diabetes.

OnFocus Healthcare, originally established in 1985 as m21partners, transformed in 2008 into a provider of business execution software solutions for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance operational efficiency within healthcare organizations. Its flagship product, onFocus epm™, enables hospitals to improve patient care by streamlining processes, thereby ensuring that care is delivered more efficiently and cost-effectively. Through its software and advisory services, OnFocus Healthcare aims to elevate the performance and execution success of healthcare providers by at least 20%. The company's commitment is to support healthcare executives, managers, and staff in achieving their organizational goals and enhancing overall patient outcomes.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company based in Nashville, Tennessee, founded in 2011. The company specializes in providing drug discovery services, including assay development and secondary screening, primarily for pharmaceutical companies. It commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free, conformation-sensitive measurement of small molecule interactions with complex drug targets, such as membrane proteins. This innovative approach enables biophysical characterization in native-like environments without the need for tags or tethering. Molecular Sensing's solutions are utilized for various applications, including secondary screening, mechanism-of-action studies, and the evaluation of allosteric and complex targets, facilitating significant advancements in drug discovery processes.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

OnFocus Healthcare, originally established in 1985 as m21partners, transformed in 2008 into a provider of business execution software solutions for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance operational efficiency within healthcare organizations. Its flagship product, onFocus epm™, enables hospitals to improve patient care by streamlining processes, thereby ensuring that care is delivered more efficiently and cost-effectively. Through its software and advisory services, OnFocus Healthcare aims to elevate the performance and execution success of healthcare providers by at least 20%. The company's commitment is to support healthcare executives, managers, and staff in achieving their organizational goals and enhancing overall patient outcomes.